Seizure measurement in clinical trials

Journal of Epilepsy

Volumn 11, Issue 5, 1998, Pages 256-260

  Cramer, Joyce A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Clinical trials; Clinimetric scale; Seizures

Indexed keywords

AUTOMATISM; CLINICAL PROTOCOL; COMPLEX PARTIAL SEIZURE; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG WITHDRAWAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 0032169960     PISSN: 08966974     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6974(98)00027-9     Document Type: Article

References (13)

1. 1. Johnson A. Statistical aspects of the measurement of clinical care in epilepsy: In: Meinardi H, Cramer JA, Baker GA, Martins da Silva A, eds. Quantitative assessment of epilepsy care. New York: Pergamon Publishing Co., 1993:11-28.
2. 2. Chadwick DM. Gabapentin: Clinical use. In: Levy RH, Mattson RH, Meldrum B, eds. Antiepileptic drugs, 4th ed. New York: Raven Press, 1995:851-6.
3. 3. Cramer JA, Smith DB, Mattson RH, Delgado-Escueta AV, Collins JF, VA Epilepsy Cooperative Study Group. A method of quantification for the evaluation of antiepileptic drug therapy. Neurology 1983;33(Suppl 1):26-37.
4. 4. Cramer JA, Mattson RH. Quantitative approaches to seizure severity. In: Meinardi H, Cramer JA, Baker GA, Martins da Silva A, eds. Quantitative assessment of epilepsy care. New York: Pergamon Publishing Co., 1993:55-72.
5. 5. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic clonic seizures. New Engl J Med 1985;313: 145-51.
6. 6. Mattson RH, Cramer JA, Collins JF, Dept. of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of partial seizures and secondarily generalized tonic - clonic seizures in adults. New Engl J Med 1992;327:765-71.
7. 7. Eslava-Cobos J. Objective measure of treatment outcome in epilepsy. Epilepsia 1996;37:572-6.
8. 8. Cramer JA. A clinimetric approach to assessing quality of life in epilepsy. Epilepsia 1993;34 (Suppl 4):S8-S13.
9. 9. O'Donoghue MF, Duncan JS, Sander JW. The National Hospital Seizure Severity scale: A further development of the Chalfont Seizure Severity Scale. Epilepsia 1996;37:563-71.
10. 10. Duncan JS, Sander JW. The Chalfont Seizure Severity Scale. J Neurol Neurosurg Psychiatry 1991;54:873-6.
11. 11. Baker GA, Smith DF, Dewey M, Morrow J, Crawford PM, Chadwick DW. The development of a seizure severity scale as an outcome measure in epilepsy. Epilepsy Res 1991;8:245-51.
12. 12. Smith D, Baker GB, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
13. 13. Wagner AK, Keller SD, Kosinski M, Baker GA, Jacoby A, Hsu MA, Chadwick DW, Ware JE. Advances in methods for assessing the impact of antiepileptic drug therapy on patients' health-related quality of life. QOL Res 1995;4:115-34.